Article Published 16 Oct 2025 Understanding The EU's International Procurement Instrument China Government, Public Sector CM Crowell & Moring LLP
Article Published 15 Oct 2025 汉坤 • 观点 | 《药品管理法实施条例》(修订草案)重点快评 China Food, Drugs, Healthcare, Life Sciences HK Han Kun Law Offices
Article Published 15 Oct 2025 汉坤 • 观点 | 中国药品年度报告制度简析 China Food, Drugs, Healthcare, Life Sciences HK Han Kun Law Offices
Article Published 15 Oct 2025 汉坤 • 观点 | 简评新版《医疗器械临床试验质量管理规范(GCP)》 China Food, Drugs, Healthcare, Life Sciences HK Han Kun Law Offices
Article Published 14 Oct 2025 Compliance Highlights And Strategies In High-Risk Clinical Research Landscape China Food, Drugs, Healthcare, Life Sciences HK Han Kun Law Offices
Article Published 14 Oct 2025 Han Kun • Opinion | Settle The Dust Or Let The Bullets Fly: Biden Administration Signs Executive Order On Promoting Biotechnology And Biomanufacturing Innovation China Food, Drugs, Healthcare, Life Sciences HK Han Kun Law Offices
Article Published 13 Oct 2025 Han Kun • Opinion | Finally Waiting For You - Interpreting The New Policy Of Cross-border Contract Production Of Drugs And Medical Devices In The Guangdong-Hong Kong-Macao Greater Bay Area China Food, Drugs, Healthcare, Life Sciences HK Han Kun Law Offices
Article Published 9 Oct 2025 Han Kun • Opinion | Interpretation Of China's Annual Drug Review Report (2015-2021) - Review Of The Reform Of Our Country's Drug Review And Approval System (Part II) China Food, Drugs, Healthcare, Life Sciences HK Han Kun Law Offices
Article Published 9 Oct 2025 Han Kun • Opinion | Interpretation Of China's Annual Drug Review Report (2015-2021) - Review Of The Reform Achievements Of Our Country's Drug Review And Approval System (Part II) China Food, Drugs, Healthcare, Life Sciences HK Han Kun Law Offices
Article Published 9 Oct 2025 汉坤 • 观点 | 医药BD项目如何友好"分手"? China Food, Drugs, Healthcare, Life Sciences HK Han Kun Law Offices
Article Published 9 Oct 2025 How Digital Therapeutics (DTx) Products Are Regulated In China? China Food, Drugs, Healthcare, Life Sciences HK Han Kun Law Offices
Article Published 9 Oct 2025 生命科学行业License-in/out合同争议要点分析(三):不竞争条款 China Food, Drugs, Healthcare, Life Sciences HK Han Kun Law Offices
Article Published 9 Oct 2025 2024 Data Analytics: China Life Sciences NewCo & Licensing Terms China Food, Drugs, Healthcare, Life Sciences HK Han Kun Law Offices
Article Published 7 Oct 2025 Han Kun • Opinion | Hainan Boao Lecheng Clinical Urgently Needs A Review Of The Highlights Of The New Regulations On The Management Of Imported Drugs And Devices China Food, Drugs, Healthcare, Life Sciences HK Han Kun Law Offices
Article Published 6 Oct 2025 Han Kun • Opinion | Key Points For The Supervision Of Medical And Three-Product And One-Device Advertising Under The New Regulations On Internet Advertising China Food, Drugs, Healthcare, Life Sciences HK Han Kun Law Offices
Article Published 6 Oct 2025 Han Kun • Opinion | Brief Review Of The Measures For The Review Of Science And Technology Ethics (Trial) (Draft For Comments) China Food, Drugs, Healthcare, Life Sciences HK Han Kun Law Offices
Article Published 3 Oct 2025 汉坤 • 观点 | CAR-T/NK监管路在何方 — 体细胞临床研究工作指引(征求意见稿)要点解读 China Food, Drugs, Healthcare, Life Sciences HK Han Kun Law Offices
Article Published 3 Oct 2025 Han Kun • Opinion | Interpretation Of The New Administrative Guidelines For Human Genetic Resources China Food, Drugs, Healthcare, Life Sciences HK Han Kun Law Offices
Article Published 3 Oct 2025 Strategic Insights For The Localization Of Pharmaceutical And Medical Device Manufacturing In China China Food, Drugs, Healthcare, Life Sciences HK Han Kun Law Offices
Article Published 3 Oct 2025 汉坤 • 观点 | LDT试点新规解读 China Food, Drugs, Healthcare, Life Sciences HK Han Kun Law Offices